Pharmacological effects of the simultaneous and sequential combinations of trifluridine/tipiracil (TAS-102) and 5-fluorouracil in fluoropyrimidine-sensitive colon cancer cells-Reference-Cited by-同舟云学术

Pharmacological effects of the simultaneous and sequential combinations of trifluridine/tipiracil (TAS-102) and 5-fluorouracil in fluoropyrimidine-sensitive colon cancer cells

Published:2019-06-01 Issue:1 Volume:38 Page:92-98
ISSN:0167-6997
Container-title:Investigational New Drugs
language:en
Short-container-title:Invest New Drugs

Author:

Orlandi Paola,Gentile Daniela,Banchi Marta,Cucchiara Federico,Di Desidero Teresa,Cremolini Chiara,Moretto Roberto,Falcone Alfredo,Bocci Guido^ORCID

Funder

University of Pisa

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10637-019-00804-5.pdf

Reference20 articles.

1. Sanchez-Gundin J, Fernandez-Carballido AM, Martinez-Valdivieso L, Barreda-Hernandez D, Torres-Suarez AI (2018) New trends in the therapeutic approach to metastatic colorectal cancer. Int J Med Sci 15(7):659–665. https://doi.org/10.7150/ijms.24453

2. Yee NS (2018) Update in systemic and targeted therapies in gastrointestinal oncology. Biomedicines 6(1). https://doi.org/10.3390/biomedicines6010034

3. Wu C (2018) Systemic therapy for colon cancer. Surg Oncol Clin N Am 27(2):235–242. https://doi.org/10.1016/j.soc.2017.11.001

4. Peeters M, Cervantes A, Moreno Vera S, Taieb J (2018) Trifluridine/tipiracil: an emerging strategy for the management of gastrointestinal cancers. Future Oncol 14(16):1629–1645. https://doi.org/10.2217/fon-2018-0147

5. Suzuki N, Nakagawa F, Nukatsuka M, Fukushima M (2011) Trifluorothymidine exhibits potent antitumor activity via the induction of DNA double-strand breaks. Exp Ther Med 2(3):393–397. https://doi.org/10.3892/etm.2011.244

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pyrimidine-based anticancer drugs;New Strategies Targeting Cancer Metabolism;2022

2. Uncovering the Effect of Passage Number on HT29 Cell Line Based on the Cell Metabolomic Approach;Journal of Proteome Research;2021-02-08

3. Discovery of oxyepiberberine as a novel tubulin polymerization inhibitor and an anti-colon cancer agent against LS-1034 cells;Investigational New Drugs;2020-09-30